JP2012522989A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012522989A5 JP2012522989A5 JP2012503660A JP2012503660A JP2012522989A5 JP 2012522989 A5 JP2012522989 A5 JP 2012522989A5 JP 2012503660 A JP2012503660 A JP 2012503660A JP 2012503660 A JP2012503660 A JP 2012503660A JP 2012522989 A5 JP2012522989 A5 JP 2012522989A5
- Authority
- JP
- Japan
- Prior art keywords
- biomarkers
- subject
- level
- acid
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16533609P | 2009-03-31 | 2009-03-31 | |
| US61/165,336 | 2009-03-31 | ||
| US16657209P | 2009-04-03 | 2009-04-03 | |
| US61/166,572 | 2009-04-03 | ||
| PCT/US2010/029399 WO2010114897A1 (en) | 2009-03-31 | 2010-03-31 | Biomarkers related to insulin resistance and methods using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012522989A JP2012522989A (ja) | 2012-09-27 |
| JP2012522989A5 true JP2012522989A5 (https=) | 2013-01-17 |
Family
ID=42828685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012503660A Pending JP2012522989A (ja) | 2009-03-31 | 2010-03-31 | インスリン抵抗性に関連するバイオマーカー、及びそれを使用する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20120122981A1 (https=) |
| EP (1) | EP2414535A4 (https=) |
| JP (1) | JP2012522989A (https=) |
| CN (1) | CN102449161A (https=) |
| BR (1) | BRPI1013387A2 (https=) |
| WO (1) | WO2010114897A1 (https=) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009001862A1 (ja) * | 2007-06-25 | 2008-12-31 | Ajinomoto Co., Inc. | 内臓脂肪蓄積の評価方法 |
| CA2690541A1 (en) | 2007-07-17 | 2009-01-29 | Metabolon, Inc. | Biomarkers for pre-diabetes, cardiovascular diseases, and other metabolic-syndrome related disorders and methods using the same |
| US10215765B2 (en) | 2010-09-15 | 2019-02-26 | Quest Diagnostics Investments Incorporated | Detection of vitamins A and E by tandem mass spectrometry |
| WO2012058298A1 (en) * | 2010-10-26 | 2012-05-03 | Mayo Foundation For Medical Education And Research | Biomarkers of reduced insulin action |
| KR101303825B1 (ko) * | 2011-06-02 | 2013-09-05 | 연세대학교 산학협력단 | 혈장 대사체를 이용한 제2형 당뇨병 진단 키트 |
| JP6260275B2 (ja) | 2011-06-30 | 2018-01-17 | 味の素株式会社 | 脂肪肝の評価方法、脂肪肝評価装置、脂肪肝評価方法、脂肪肝評価プログラム、脂肪肝評価システム、および端末装置 |
| WO2013039898A1 (en) * | 2011-09-14 | 2013-03-21 | Metabolon, Inc. | Biomarkers related to insulin resistance and methods using the same |
| EP2642295A1 (en) * | 2012-03-22 | 2013-09-25 | Nestec S.A. | 1-O-alkyl-2-acylglycerophosphocholine (PC-O) 40:1 as biomarker for healthy ageing |
| EP2642293A1 (en) | 2012-03-22 | 2013-09-25 | Nestec S.A. | 9-oxo-octadecadienoic acid (9-oxo-HODE)as as biomarker for healthy ageing |
| US9928345B2 (en) | 2012-06-08 | 2018-03-27 | Liposciences, Inc. | Multiple-marker risk parameters predictive of conversion to diabetes |
| US9361429B2 (en) * | 2012-06-08 | 2016-06-07 | Liposcience, Inc. | Multi-parameter diabetes risk evaluations |
| US9470771B2 (en) | 2012-06-08 | 2016-10-18 | Liposcience, Inc. | NMR measurements of NMR biomarker GlycA |
| CN104769434B (zh) * | 2012-08-13 | 2018-01-02 | 亥姆霍兹慕尼黑中心德国研究健康与环境有限责任公司 | 用于2型糖尿病的生物标志物 |
| US20140324460A1 (en) * | 2012-09-26 | 2014-10-30 | Health Diagnostic Laboratory, Inc. | Method for determining and managing total cardiodiabetes risk |
| WO2014105858A1 (en) * | 2012-12-26 | 2014-07-03 | Quest Diagnostics Investments Incorporated | C peptide detection by mass spectrometry |
| EP2943790A1 (en) | 2013-01-11 | 2015-11-18 | Health Diagnostic Laboratory, Inc. | Method of detection of clinically significant post-prandial hyperglycemia in normoglycemic patients |
| ES2987582T3 (es) * | 2013-01-31 | 2024-11-15 | Metabolon Inc | Biomarcadores relacionados con la progresión de la resistencia a la Insulina y métodos que lo utilizan |
| US20140278121A1 (en) * | 2013-03-13 | 2014-09-18 | Robust for Life, Inc. | Systems and methods for network-based calculation and reporting of metabolic risk |
| WO2015057315A1 (en) * | 2013-09-04 | 2015-04-23 | Kelly Joseph Michael Lawless | Methods and systems for the detection of disease |
| EP3805756A1 (en) * | 2014-04-08 | 2021-04-14 | Metabolon, Inc. | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment |
| JP6051258B2 (ja) * | 2015-04-15 | 2016-12-27 | ライオン株式会社 | 脂質異常症への罹患しやすさを試験する方法 |
| JP6051257B2 (ja) * | 2015-04-15 | 2016-12-27 | ライオン株式会社 | 脂質異常症への罹患しやすさを試験する方法 |
| WO2017070114A2 (en) * | 2015-10-18 | 2017-04-27 | Wei Jia | Diabetes-related biomarkers and treatment of diabetes-related conditions |
| GB201522302D0 (en) * | 2015-12-17 | 2016-02-03 | Mars Inc | Food product for regulating lipid metabolites |
| CN106093430A (zh) * | 2016-06-06 | 2016-11-09 | 上海阿趣生物科技有限公司 | 可用于检测糖尿病的标志物及其用途 |
| CN107022018B (zh) * | 2016-08-16 | 2018-04-13 | 北京毅新博创生物科技有限公司 | 检测胰岛素抵抗的组合物及产品和用途 |
| CN106442770B (zh) * | 2016-09-05 | 2019-01-18 | 南京医科大学 | 与特发性男性不育相关的精浆代谢小分子标志物及其检测方法和应用 |
| CN106908605B (zh) * | 2017-01-22 | 2019-02-22 | 中国人民解放军军事医学科学院基础医学研究所 | eLtaS蛋白作为预防和治疗胰岛素抵抗相关疾病的药物靶点的应用 |
| WO2019034719A1 (en) * | 2017-08-17 | 2019-02-21 | Nestec S.A. | PRE-PUBERTÉ MARKERS FOR CHILD PRÉDIABÈTE |
| CN108623655B (zh) * | 2018-05-15 | 2020-09-01 | 浙江省农业科学院 | 改善胰岛素抵抗的二肽el及其用途 |
| CN109298084A (zh) * | 2018-07-23 | 2019-02-01 | 上海市东方医院 | 用于检测血清或者血浆中油酸浓度的试剂盒及其制备方法和应用 |
| EP3857232A1 (en) * | 2018-09-27 | 2021-08-04 | Société des Produits Nestlé S.A. | Markers of risk to develop insulin resistance during childhood and young adulthood |
| CN110887808A (zh) * | 2019-10-28 | 2020-03-17 | 广东省测试分析研究所（中国广州分析测试中心） | 一种红外光谱技术快速检测阿卡波糖发酵过程中的糖源含量的方法 |
| CN112903885B (zh) * | 2019-12-03 | 2022-05-06 | 中国科学院大连化学物理研究所 | 一种筛查糖尿病的联合型代谢标志物的应用及其试剂盒 |
| CN213980949U (zh) | 2020-08-27 | 2021-08-17 | 康明斯电力公司 | 用于发电机组的系统 |
| CN112461986B (zh) * | 2021-02-03 | 2021-06-08 | 首都医科大学附属北京友谊医院 | 一种用于评估空腹血糖受损和2型糖尿病患病风险的整合生物标志物体系 |
| EP3922990B1 (en) | 2021-03-28 | 2024-05-08 | MS Ekspert Sp. z o.o. | System for automatic changing and sealing of disposable chromatographic columns in high-performance liquid chromatography; measurement method and its application in the analysis of biomarker of rare disease |
| CN113929762B (zh) * | 2021-12-16 | 2022-04-26 | 清华大学 | 3-羟基丁酰化和/或3-羟基戊酰化修饰胰岛素及其应用 |
| CN117159717A (zh) * | 2023-09-28 | 2023-12-05 | 广东省人民医院 | Slc25a33在制备预防或治疗葡萄糖代谢相关疾病的药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997031103A1 (en) * | 1996-02-20 | 1997-08-28 | Kyowa Hakko Kogyo Co., Ltd. | Method for determining 1,5-anhydroglucitol |
| WO2002098355A2 (en) * | 2001-06-01 | 2002-12-12 | Clingenix, Inc. | Methods and reagents for diagnosis and treatment of insulin resistance and related conditions |
| US7425545B2 (en) * | 2001-07-25 | 2008-09-16 | Isis Pharmaceuticals, Inc. | Modulation of C-reactive protein expression |
| CN101802620A (zh) * | 2007-02-22 | 2010-08-11 | 特提斯生物科学公司 | 糖尿病状况的代谢标志物及其使用方法 |
| CA2690541A1 (en) * | 2007-07-17 | 2009-01-29 | Metabolon, Inc. | Biomarkers for pre-diabetes, cardiovascular diseases, and other metabolic-syndrome related disorders and methods using the same |
-
2010
- 2010-03-31 EP EP10759343A patent/EP2414535A4/en not_active Withdrawn
- 2010-03-31 WO PCT/US2010/029399 patent/WO2010114897A1/en not_active Ceased
- 2010-03-31 JP JP2012503660A patent/JP2012522989A/ja active Pending
- 2010-03-31 US US13/258,780 patent/US20120122981A1/en not_active Abandoned
- 2010-03-31 BR BRPI1013387-9A patent/BRPI1013387A2/pt not_active Application Discontinuation
- 2010-03-31 CN CN2010800240217A patent/CN102449161A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012522989A5 (https=) | ||
| JP2015064362A5 (https=) | ||
| Kang et al. | Metabolic profiling regarding pathogenesis of idiopathic pulmonary fibrosis | |
| JP6927212B2 (ja) | 軽度認知障害又はアルツハイマー型認知症の評価方法 | |
| Lehmann et al. | Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver | |
| Noto et al. | Metabolomics in newborns | |
| JP2010537157A5 (https=) | ||
| JP6870679B2 (ja) | アルツハイマー型認知症の将来の発症リスクの評価方法 | |
| JP2016520192A5 (https=) | ||
| JP2016509222A (ja) | インスリン抵抗性の進行に関連するバイオマーカー及びこれを使用する方法 | |
| Zhang et al. | Machine learning applied to serum and cerebrospinal fluid metabolomes revealed altered arginine metabolism in neonatal sepsis with meningoencephalitis | |
| Cassol et al. | Altered monoamine and acylcarnitine metabolites in HIV-positive and HIV-negative subjects with depression | |
| Liu et al. | Dynamic proteomic analysis of protein expression profiles in whole brain of Balb/C mice subjected to unpredictable chronic mild stress: implications for depressive disorders and future therapies | |
| JP2014532168A5 (https=) | ||
| JP2012521551A5 (https=) | ||
| ES2749048T3 (es) | Biomarcadores para evaluar el VIH | |
| Yang et al. | Metabolomics in viral hepatitis: advances and review | |
| CN103837620A (zh) | 一种同时检测人体血浆中多种氨基酸含量的方法 | |
| JP6762529B2 (ja) | 腎臓病の病態バイオマーカー | |
| Han et al. | Plasma advanced glycation endproduct, methylglyoxal-derived hydroimidazolone is elevated in young, complication-free patients with Type 1 diabetes | |
| Bratt et al. | Arginase enzymes in isolated airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin | |
| Gonçalves et al. | Comparative salivary proteome of hepatitis B-and C-infected patients | |
| Liu et al. | The interaction of ammonia and manganese in abnormal metabolism of minimal hepatic encephalopathy: a comparison metabolomics study | |
| Wang et al. | The role of metabolomics in stroke: biomarkers of diagnosis and therapy | |
| CN104678003A (zh) | 尿液用于评估肝癌症疾病的生物标记物 |